Differential expression of transforming growth factors-ß1, -ß2, -ß3 and the type I, II, III receptors in the lining epithelia of inflamed gingiva

References

• Presland RB, Jurevic RJ. Making sense of the epithelial barrier: what molecular biology and genetics tell us about the functions of oral mucosal and epidermal tissues. J Dent Educ 2002; 66: 564–74.
   PubMedGoogle Scholar
• Vaahtokari A, Vainio S, Thesleff I. Associations between transform-ing gowth factor beta 1RNA expression and epithelial-mesenchymal interactions during tooth morphogenesis. Development 1991; 113: 985–94.
   Google Scholar
• Ye P, Chapple CC, Kumar RK, Hunter N. Expression patterns of E-cadherin, involucrin and connexin gap junction proteins in the lining epithelia of inflamed gingiva. J Pathol 2000; 192: 58–66.
   PubMed Web of Science ®Google Scholar
• Downer CS, Speight PM. E-cadherin expression in normal, hyper-plastic and malignant oral epithelium. Oral Oncol, Eur J Cancer 1993; 29B: 303–5.
   PubMed Web of Science ®Google Scholar
• Ciacci C, Lind SE, Podolsky DK. Transforming growth factor ri regulation of migration in wounded rat intestinal epithelial mono-layers. Gastroenterology 1993; 105: 93–101.
   Google Scholar
• Massague J. The transforming growth factor-n family. Annu Rev Cell Biol 1990; 6: 597–641.
   PubMedGoogle Scholar
• Moses HL, Arteaga CL, Alexandrow MG, et al. TGF beta regulation of cell proliferation. Princess Takamatsu Symposia 1994; 24: 250–63.
   PubMedGoogle Scholar
• Wahl SM, Costa GL, Mizel DE, Allen JB, Skaleric U, Mangan DF. Role of transforming growth factor beta in the pathophysiology of chronic inflammation. J Periodontol 1993; 64: 450–5.
   PubMed Web of Science ®Google Scholar
• Letterio ii, Roberts AB. Regulation of immune responses by TGF-ri. Annu Rev Immunol 1998; 16: 137–61.
   PubMed Web of Science ®Google Scholar
• Gorelik L, Flavell RA. Transforming growth factor-n in T-cell biology. Nat Rev Immunol 2002; 2: 46–53.
   PubMed Web of Science ®Google Scholar
• Lomo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB. TGF-r31 and cyclic AMP promote apoptosis in resting human B lymphocyte. J Immunol 1995; 15: 1634–43.
   Google Scholar
• Wrana JL, Attisano L, Carcamo J, et al. TGF-r3 signals through a heteromeric protein kinase receptor complex. Cell 1992; 71: 1003–14.
   PubMed Web of Science ®Google Scholar
• Stach RM, Rowley DA. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med 1993; 178: 841–52.
   Google Scholar
• Prime SS, Nixon SVR, Crane II, et al. The behaviour of human oral squamous cell carcinoma in cell culture. J Pathol 1990; 160: 259–69.
   PubMed Web of Science ®Google Scholar
• Pircher R, Lawrence DA, Jullien P. Latent transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells. Cancer Res 1984; 44: 5538–43.
   Google Scholar
• DeCarlo AA, Grenett HE, Harber GJ, et al. Induction of matrix metallo-proteinases and a collagen-degrading phenotype in fibroblasts and epithelial cells by secreted Porphyromonas gingivalis proteinase. J Periodont Res 1998; 33: 408–20.
   PubMed Web of Science ®Google Scholar
• Massague J. Receptors for the TGF-ri family. Cell 1992; 69: 1067–70.
   PubMed Web of Science ®Google Scholar
• Ebner R, Shum L, Lawler S, et al. Cloning of a type I TGFP receptor and its effect on TGF0 binding to the type II receptor. Science 2001; 260: 1344–7.
   Web of Science ®Google Scholar
• Cheifetz S, Massague J. Transforming growth factor-beta (TGF-beta) receptor proteoglycan. Cell surface expression and ligand binding in the absence of glycosaminoglycan chains. J Biol Chem 1989; 264: 12 025–8.
   Google Scholar
• Wataya-Kaneda M, Hashimoto K, Kato M, Miyazono K, Yoshikawa K. Differential localization of TGF-0-precursor isotypes in psoriatic human skin. J Dermatological Sci 1996; 11: 183–8.
   Google Scholar
• Nishida K, Kinoshita S, Yokoi N, Kaneda M, Hashimoto K, Yamamoto S. Immunohistochemical localization of transforming growth factor-01, -02, and -03 latency-associated peptide in human cornea. Invest Ophthalmol Vis Sci 1994; 35: 3289–94.
   PubMed Web of Science ®Google Scholar
• Schmid P, Itin P, Rufli T. In situ analysis of transforming growth factor-beta (TGF-beta 1, TGF-beta 2, TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas. Br J Dermatol 1996; 134: 1044–51.
   Google Scholar
• Skaleric U, Kramar B, Petelin M, Pavlica Z, Wahl SM. Changes in TGF-01 levels in gingiva, crevicular fluid and serum associated with periodontal inflammation in humans and dogs. Eur J Oral Scl 1997; 105: 136–42.
   Google Scholar
• Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693–9.
   PubMed Web of Science ®Google Scholar
• Hedberg NM, Hunter N. The expression of HLA-DR on keratino-cytes in oral lichen planus. J Oral Pathol 1987; 16: 31–5.
   PubMedGoogle Scholar
• Ye P, Harty DWS, Chapple CC, Nadkarni MA, DeCarlo AA, Hunter N. Streptococci and Actinomyces induce antibodies which are cross-reactive with epithelial antigens in periodontitis. Clin Exp Immunol 2003; 131: 468–76.
   PubMed Web of Science ®Google Scholar
• Berghuis HM, Dieudonne SC, Goei W, Veldhuijzen JP. Effects of TGF-beta 2 on mineral resorption in cultured embryonic mouse long bones; 45Ca release and osteoclast differentiation and migration. Eur J Orthod 1994; 16: 130–37.
   PubMed Web of Science ®Google Scholar
• Sankar S, Mahooti-Brooks N, Centrella M, McCarthy TL, Madri JA. Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor [32. J Biol Chem 1995; 270: 13567–72.
   PubMed Web of Science ®Google Scholar
• Brown CB, Boyer AS, Runyan RB, Barnett JV. Requirement for type III TGF-0 receptor for endocardial cell transformation in the heart. Science 1999; 283: 2080–82.
   PubMed Web of Science ®Google Scholar
• Rotzer D, Roth M, Lutz M, Lindermann D, Sebald W, Knaus P. Type III TGF-0 receptor-independent signalling of TGF-02 via TPRII-B, an alternatively spliced TGF-13 type II receptor. EMBO J 2001; 20: 480–90.
   PubMed Web of Science ®Google Scholar
• Shah M, Foreman DM, Ferguson MWJ. Neutralisation of TGF-01 and TGF-02 or exogenous addition of TGF-03 to cutaneous rat wounds reduces scarring. J Cell Scl 1995; 108: 985–1002.
   Google Scholar
• FitzPatrick DR, Denhez F, Kondaiah P, Akhurst RJ. Differential expression of TGF beta isoforms in murine palatogenesis. Develop-ment 1990; 109: 585–95.
   PubMed Web of Science ®Google Scholar
• Hunter N, Nicholls B, Srivastava M, Chapple C, Zoellner H, Gibbins JR. Reactive pocket epithelium in untreated periodontal disease: possible derivation from developmental remnants of the enamel organ and root sheath. J Oral Path Med 2001; 30: 178–86.
   PubMed Web of Science ®Google Scholar